{"id":5845,"date":"2025-11-28T15:39:19","date_gmt":"2025-11-28T10:09:19","guid":{"rendered":"http:\/\/www.insurancesamadhan.com\/blog\/?p=5845"},"modified":"2025-12-15T10:57:44","modified_gmt":"2025-12-15T05:27:44","slug":"cancer-treatment-in-india-is-changing-rapidly-but-insurance-coverage-hasnt-kept-pace","status":"publish","type":"post","link":"http:\/\/www.insurancesamadhan.com\/blog\/cancer-treatment-in-india-is-changing-rapidly-but-insurance-coverage-hasnt-kept-pace\/","title":{"rendered":"Cancer treatment in India is changing rapidly \u2014 but insurance coverage hasn\u2019t kept pace."},"content":{"rendered":"\n

A recent report  highlights that health insurers, on average, cover only about 70% of cancer-treatment expenses<\/strong>, leaving thousands of families to manage the remaining cost themselves. Despite having health insurance, many policyholders still end up paying lakhs out-of-pocket for chemotherapy, targeted therapy, immunotherapy and newer FDA-approved cancer drugs.<\/p>\n\n\n\n

This gap between coverage promised<\/em> and coverage received<\/em> is where most claim disputes arise \u2014 and where awareness is urgently needed.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Where the Gap Began: IRDAI Guidelines of 27 September 2019<\/strong><\/p>\n\n\n\n

The IRDAI Standardisation of Exclusions Guidelines (2019)<\/strong> provided benchmark rules for what treatments could or could not be excluded under a health insurance policy. While it was a progressive move at the time, these guidelines did not anticipate the medical advancements that emerged afterward \u2014 especially in cancer care.
Since 2019, oncology has seen tremendous breakthroughs:<\/p>\n\n\n\n

    \n
  1. Targeted drugs<\/strong>
    <\/strong><\/li>\n\n\n\n
  2. Immunotherapy & monoclonal antibodies<\/strong>
    <\/strong><\/li>\n\n\n\n
  3. Oral chemo drugs<\/strong>
    <\/strong><\/li>\n\n\n\n
  4. Personalised & gene-based cancer therapies<\/strong><\/li>\n<\/ol>\n\n\n\n

    However, many of these fall into grey areas<\/em> of policy coverage. This creates confusion and, often, claim rejection or partial approvals that leave families financially burdened.<\/p>\n\n\n\n

    Why Policyholders Are Struggling<\/strong><\/p>\n\n\n\n

    Insurance Samadhan regularly receives queries from cancer patients, caregivers, pharma stakeholders and support groups asking the same question:<\/p>\n\n\n\n

    Why are life-saving modern cancer treatments not clearly covered under health insurance?<\/strong><\/p>\n\n\n\n

    The issue is simple: policies reference the 2019 framework, while treatment science in 2025 has moved far ahead. When coverage clarity is missing, reimbursement becomes complex \u2014 and claim disputes increase.<\/p>\n\n\n\n

    The Need for Regulatory Revision<\/strong><\/p>\n\n\n\n

    To protect policyholders, the industry must evolve. India needs updated IRDAI guidelines<\/strong> that:<\/p>\n\n\n\n

      \n
    1. Clearly recognise modern cancer therapies
      <\/li>\n\n\n\n
    2. Define coverage terms for new drugs
      <\/li>\n\n\n\n
    3. Reduce ambiguity on exclusions & sub-limits
      <\/li>\n\n\n\n
    4. Improve transparency in policy wording
      <\/li>\n\n\n\n
    5. Ensure that \u201ccancer cover\u201d actually covers today\u2019s<\/em> cancer treatment<\/li>\n<\/ol>\n\n\n\n

      Insurance is meant to reduce financial trauma<\/em>, not redirect it.<\/p>\n\n\n\n

      How Insurance Samadhan Helps<\/strong><\/p>\n\n\n\n

      At Insurance Samadhan<\/strong>, we work with policyholders facing claim denials, partial settlements, non-disclosure issues, co-pay disputes and exclusion-based rejections<\/strong>. Our team helps interpret policies, draft representation, analyse treatment narratives and escalate cases when necessary \u2014 so you can focus on recovery, not paperwork.<\/p>\n\n\n\n

      We stand for fair treatment, clarity in cancer coverage, and better protection for Indian families.<\/strong><\/p>\n\n\n

      <\/p>\n

      Click here to register your complaint with Insurance Samadhan<\/strong><\/a><\/p>\n

      Visit our website:\u00a0insurancesamadhan.com<\/a><\/p>\n

      Mail us at\u00a0corporate@insurancesamadhan.com<\/a><\/p>\n

      <\/p>\n\n\n

      Does health insurance cover cancer in India?<\/strong><\/strong>

      Yes, but coverage varies. Many policies cover hospitalisation & chemo, but modern drugs and targeted therapies may not be fully covered.<\/p> <\/div>

      Why does cancer insurance pay only 70% of costs?<\/strong><\/strong>

      Because of sub-limits, exclusions, drug restrictions and outdated coverage standards under IRDAI guidelines issued in 2019.<\/p> <\/div>

      Are targeted cancer drugs covered by insurance?<\/strong><\/strong>

      Some are, many are not. Coverage clarity depends on policy wording. Always check exclusions before treatment.<\/p> <\/div>

      Can Oncology immunotherapy be claimed under health insurance?<\/strong><\/strong>

      Yes, in some policies \u2014 but may require justification. Documentation strength impacts approval.<\/p> <\/div>

      How can I fight a rejected cancer insurance claim?<\/strong><\/strong>

      Seek expert support from Insurance Samadhan to review documents, draft representation and escalate if needed.<\/p> <\/div>

      Will IRDAI revise cancer-treatment guidelines?<\/strong><\/strong>

      Medical advancement now demands revision. Industry stakeholders, including cancer groups & pharma, are pushing for it.<\/p> <\/div> <\/div>\n\n\n\n

      <\/p>\n\n\n\t\n

      <\/p>\n\n\n